| Matthew D Garris, PA-C | |
|
407 S. 19th St, Blair, NE 68008 | |
| (402) 533-2223 | |
| (531) 301-6272 |
| Full Name | Matthew D Garris |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 407 S. 19th St, Blair, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376610097 | NPI | - | NPPES |
| 38785 | Other | NE | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 900 (Nebraska) | Secondary |
| 363A00000X | Physician Assistant | 900 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Matthew D Garris, PA-C 407 S. 19th St, Blair, NE 68008 Ph: (402) 533-2223 | Matthew D Garris, PA-C 407 S. 19th St, Blair, NE 68008 Ph: (402) 533-2223 |
News Archive
Health Dialog, a leading provider of healthcare decision programs, today announced that two of its customers received DMAA Awards for excellence in improving overall population-based healthcare.
Commenting on an initial outline from the Medicare Payment Advisory Commission (MedPAC) to address the sustainable growth rate formula used to fund physicians, the Alliance for Quality Nursing Home Care said news reports of proposed Medicare cuts of $49 billion over ten years for post-acute care providers - on top of the many cuts already in effect - would severely undermine seniors' care, jeopardize local jobs, and further destabilize a key U.S. health sector already reeling from a series of budgetary and regulatory actions.
Endo Pharmaceuticals today announced actions designed to advance the company's leadership and growth in pain management, including an agreement to acquire all outstanding shares of Penwest Pharmaceuticals for $5.00 in cash per share, or an estimated enterprise value of approximately $144 million at the time of deal close. Penwest has been working with Endo since 1997 on the development and commercialization of OPANA® ER and receives a royalty stream on net sales of the product.
AN INNOVATIVE treatment helping patients with overactive bladder symptoms lead normal lives again has been licensed for use by the UK's medicines watchdog following a landmark study in which Sheffield Teaching Hospitals NHS Foundation Trust played a leading role.
According to Millennium Research Group, the global authority on medical technology market intelligence, the new reimbursement system from the Centers for Medicare & Medicaid Services for end stage renal disease will have a mixed but mostly negative effect on the market for ESRD treatment devices.
› Verified 1 days ago
Mark P Christiansen, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 812 N 22nd St, Blair, NE 68008 Phone: 402-426-4611 Fax: 402-426-4642 | |
Lynda D Arnold, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 812 N 22nd St, Blair, NE 68008 Phone: 402-426-4611 Fax: 402-426-4642 | |
Susan Ryan, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 718 S 19th St, Blair, NE 68008 Phone: 402-426-5171 | |
Bruce L Town, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 812 N 22nd St, Blair, NE 68008 Phone: 402-426-4611 Fax: 402-426-4642 | |
Cameron J Ourada, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 810 N 22nd St, Blair, NE 68008 Phone: 402-426-1629 Fax: 402-426-1297 | |
Mrs. Nicole Catherine Kratochvil, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 812 N 22nd St, Blair, NE 68008 Phone: 402-426-4611 Fax: 402-426-4642 |